Record NNP B-NP O
date NN I-NP O
: : O O
2136-12-05 CD O B-DATE
HIGHLAND NNP B-NP B-HOSPITAL
HOSITAL NNP I-NP I-HOSPITAL
VISIT NNP I-NP O
PT NNP B-NP O
: : O O
Ellen NNP B-NP B-PATIENT
Law NNP I-NP I-PATIENT
date NN B-NP O
of IN B-PP O
visit NN B-NP O
: : O O
12/05/36 CD O B-DATE
CC NNP B-NP O
: : O O
fu NN B-NP O
cards NNS I-NP O
, , O O
htn RB B-ADVP O
, , O O
hyperlipidemia NN B-NP O
, , O O
DM . O O
HPI NNP B-NP O
: : O O
Since IN B-PP O
our PRP$ B-NP O
last JJ I-NP O
visit NN I-NP O
, , O O
saw VBD B-VP O
Cardiology NNP B-NP O
re VB B-VP O
her PRP$ B-NP O
neck NN I-NP O
and CC I-NP O
jaw NN I-NP O
pain NN I-NP O
w VBD B-VP O
exertion NN B-NP O
, , O O
Dr. NNP B-NP O
Uphoff NNP I-NP B-DOCTOR
who WP B-NP O
feels VBZ B-VP O
that IN B-SBAR O
she PRP B-NP O
has VBZ B-VP O
stable JJ B-NP O
angina NN I-NP O
. . O O
he PRP B-NP O
recommended VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
optimize VBP B-VP O
her PRP$ B-NP O
medical JJ I-NP O
management NN I-NP O
by IN B-PP O
increasing VBG B-VP O
her PRP$ B-NP O
BB NNP I-NP O
and CC I-NP O
CCB. NNP I-NP O
At IN B-PP O
this DT B-NP O
point NN I-NP O
, , O O
she PRP B-NP O
has VBZ B-VP O
increased VBN I-VP O
her PRP$ B-NP O
BB NNP I-NP O
to TO B-PP O
2 CD B-NP O
pills NNS I-NP O
2x IN B-PP O
per IN B-PP O
day NN B-NP O
. . O O
she PRP B-NP O
feels VBZ B-VP O
ok NN B-NP O
on IN B-PP O
this DT B-NP O
. . O O
no DT B-NP O
lightheadedness NN I-NP O
or CC I-NP O
dizziness NN I-NP O
. . O O
She PRP B-NP O
is VBZ B-VP O
also RB I-VP O
going VBG I-VP O
to TO I-VP O
start VB I-VP O
nitrates NNS B-NP O
as RB B-ADVP O
soon RB I-ADVP O
as IN B-SBAR O
they PRP B-NP O
arrive--imdur VBP B-VP O
30mg JJ B-NP O
qd NN I-NP O
. . B-VP O
still RB I-VP O
having VBG I-VP O
intermittenly JJ B-NP O
jaw NN I-NP O
discomfort NN I-NP O
walking VBG B-VP O
up IN B-PP O
stairs NNS B-NP O
. . O O
no NN B-VP O
chest NN B-NP O
pressure NN I-NP O
or CC I-NP O
jaw NN I-NP O
discomfort NN I-NP O
at IN B-PP O
rest NN B-NP O
. . O O
she PRP B-NP O
has VBZ B-VP O
not RB I-VP O
gained VBN I-VP O
any DT B-NP O
wt NN I-NP O
. . O O
however RB B-ADVP O
, , O O
has VBZ B-VP O
not RB I-VP O
been VBN I-VP O
able JJ B-ADJP O
to TO B-VP O
increase VB I-VP O
her PRP$ B-NP O
lantus NN I-NP O
bc IN B-SBAR O
she PRP B-NP O
was VBD B-VP O
not RB I-VP O
sent VBN I-VP O
the DT B-NP O
correct JJ I-NP O
amount NN I-NP O
and CC O O
would MD B-VP O
run VB I-VP O
out RP B-PRT O
if IN B-SBAR O
she PRP B-NP O
increaesd VBD B-VP O
to TO I-VP O
previously RB I-VP O
recommended VBN I-VP O
dose NN B-NP O
. . O O
also RB B-ADVP O
started VBD B-VP O
pravastain RB B-ADVP O
since IN B-PP O
our PRP$ B-NP O
last JJ I-NP O
visit NN I-NP O
. . O O
has VBZ B-VP O
not RB I-VP O
noticed VBN I-VP O
any DT B-NP O
muscle NN I-NP O
aches NNS I-NP O
or CC O O
generalized JJ B-NP O
weakness NN I-NP O
. . O O
has VBZ B-VP O
only RB I-VP O
been VBN I-VP O
on IN B-PP O
this DT B-NP O
for IN B-PP O
2 CD B-NP O
weeks NNS I-NP O
though RB B-ADVP O
. . O O
no DT B-NP O
hypoglycemia NN I-NP O
; : O O
good JJ B-NP O
energy NN I-NP O
; : O O
feeling VBG B-VP O
well RB B-ADJP O
overall JJ I-ADJP O
. . O O
describes VBZ O O
feeling NN B-NP O
pressure NN I-NP O
, , O O
fullness RB B-ADVP O
in IN B-PP O
left JJ B-NP O
ear NN I-NP O
; : O O
slight JJ B-NP O
decrease NN I-NP O
in IN B-PP O
hearing NN B-NP O
. . O O
Problems NNS B-NP O
Diabetes NNP B-NP O
mellitus NN I-NP O
Malignant JJ B-NP O
tumor NN I-NP O
of IN B-PP O
urinary JJ B-NP O
bladder NN I-NP O
: : O O
stage NN B-NP O
1 CD I-NP O
, , O O
now RB B-ADVP O
s/p JJ B-NP O
bcg NN I-NP O
treatment NN I-NP O
, , O O
followed VBN B-VP O
by IN B-PP O
urology NN B-NP O
Hypertensive NNP B-NP O
disorder NN I-NP O
Obesity NN B-NP O
Retinal NNP B-NP O
detachment NN I-NP O
: : O O
s/p NN B-NP O
repair NN I-NP O
Dr. NNP I-NP O
Cleveland NNP I-NP B-DOCTOR
Medications NNS B-NP O
Aspirin NNP B-NP O
(ACETYLSALICYLIC NN I-NP O
ACID NNP I-NP O
) -RRB- I-NP O
81 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
81MG NN I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP B-NP O
#90 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Cozaar NNP B-NP O
( -LRB- B-VP O
LOSARTAN NNP B-NP O
) -RRB- I-NP O
50 CD I-NP O
MG NN I-NP O
( -LRB- I-NP O
50MG JJ I-NP O
TABLET NN I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP I-NP O
, , O O
Member NNP B-NP O
ID NNP I-NP O
# # I-NP O
55080437876 CD I-NP B-IDNUM
# # I-NP O
180 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Hydrochlorothiazide NNP B-NP O
25 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
25MG VBD I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP I-NP O
, , O O
Member NNP B-NP O
ID NNP I-NP O
# # I-NP O
033388269 CD I-NP B-IDNUM
#90 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Imdur NN B-NP O
ER NNP I-NP O
( -LRB- I-NP O
ISOSORBIDE NNP I-NP O
MONONITRATE NNP I-NP O
( -LRB- I-NP O
SR) NN I-NP O
) -RRB- O O
30 CD B-NP O
MG NN I-NP O
( -LRB- O O
30 CD B-NP O
MG NN I-NP O
TAB.SR JJ I-NP O
24H . O O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP B-NP O
#90 CD I-NP O
TAB.SR . O O
Lantus NNP B-NP O
( -LRB- I-NP O
INSULIN NN I-NP O
GLARGINE NNP I-NP O
) -RRB- I-NP O
100 CD I-NP O
U/ML NNP I-NP O
VIAL NNP I-NP O
ML NNP I-NP O
SC NNP I-NP O
AS IN B-PP O
DIRECTED NNP B-NP O
, , O O
65U JJ B-ADJP O
before IN B-PP O
breakfast NN B-NP O
and CC I-NP O
10 CD I-NP O
units NNS I-NP O
at IN B-PP O
night NN B-NP O
Member NNP I-NP O
ID NNP I-NP O
# # I-NP O
033388269 CD I-NP B-IDNUM
# # O O
3 CD B-NP O
Month( JJ I-NP O
s PRP B-NP O
) -RRB- O O
Supply NN O O
Metformin NNP B-NP O
1000 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
1000MG VBD I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
BID NNP B-PP O
# # B-NP O
180 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Metoprolol NNP B-NP O
TARTRATE JJ I-NP O
50 CD I-NP O
MG NN I-NP O
( -LRB- I-NP O
50MG JJ I-NP O
TABLET NN I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD NNP B-NP O
AS IN B-PP O
DIRECTED NNP B-NP O
, , O O
2 CD B-NP O
PO NN I-NP O
QAM NN I-NP O
AND CC O O
1 CD B-NP O
PO NN I-NP O
QPM IN B-PP O
# # B-NP O
180 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Norvasc NNP B-NP O
( -LRB- I-NP O
AMLODIPINE NNP I-NP O
) -RRB- I-NP O
5 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
5 CD I-NP O
MG NNP I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NNP I-NP O
QD NNP I-NP O
x NN I-NP O
90 CD B-NP O
days NNS I-NP O
#90 IN B-PP O
Tablet( NN B-NP O
s VBZ B-VP O
) -RRB- O O
Novolog NNP B-NP O
flexpens VBZ B-VP O
SC NNP B-NP O
AC NNP I-NP O
AS IN B-PP O
DIRECTED NNP B-NP O
, , O O
10U CD B-NP O
before IN B-PP O
breakfast NN B-NP O
, , O O
10U PRP B-NP O
before IN B-PP O
lunch NN B-NP O
, , O O
20U PRP B-NP O
before RB B-ADVP O
dinner NN B-VP O
# # B-NP O
15 CD I-NP O
prefilled VBN I-NP O
pens NNS I-NP O
One CD B-NP O
touch NN I-NP O
ultra NN I-NP O
test NN I-NP O
strips NNS I-NP O
1 CD B-NP O
SC NNP I-NP O
BID NNP I-NP O
# # O O
3 CD B-NP O
Month( JJ I-NP O
s PRP B-NP O
) -RRB- O O
Supply NN O O
Pravastatin NNP B-NP O
20 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
20MG VBD I-NP O
TABLET NNP I-NP O
Take VB B-VP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QHS NNP B-NP O
#90 CD I-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- O O
Solostar NNP B-NP O
prefilled VBD B-VP O
disposable JJ B-NP O
lantus NN I-NP O
insulin NN I-NP O
pen NN I-NP O
65 CD B-NP O
UNITS NNP I-NP O
SC NNP I-NP O
qd NNP I-NP O
, , O O
Member NNP B-NP O
ID# NNP I-NP O
033388269 VBD B-VP B-IDNUM
# # B-NP O
3 CD I-NP O
Month( JJ B-ADJP O
s PRP B-PP O
) -RRB- B-NP O
Supply NN I-NP O
Zostavax NNP B-NP O
( -LRB- I-NP O
ZOSTER NNP I-NP O
VACCINE NNP I-NP O
LIVE CD I-NP O
( -LRB- I-NP O
PF) NN I-NP O
) -RRB- I-NP O
1 CD I-NP O
VIAL NNP I-NP O
SC NNP I-NP O
X1 NNP I-NP O
x NN I-NP O
365 CD B-NP O
days NNS I-NP O
, , O O
1 CD B-NP O
. . O O
Reconstitute NNP O O
and CC O O
inject VB B-VP O
1 CD B-NP O
vial JJ I-NP O
. . O O
Sub-cutaneous JJ B-NP O
upper JJ I-NP O
arm NN I-NP O
. . O O
2. '' O O
Please VB B-VP O
document NN B-NP O
vaccine NN I-NP O
administration NN I-NP O
in IN B-PP O
the DT B-NP O
LMR NNP I-NP O
immunization NN I-NP O
module NN I-NP O
( -LRB- I-NP O
or CC O O
notify VB B-VP O
the DT B-NP O
practice NN I-NP O
in IN B-PP O
writing VBG B-VP O
if IN B-PP O
no DT B-NP O
LMR JJ I-NP O
access NN I-NP O
) -RRB- I-NP O
. . O O
# # O O
1 CD O O
vial CD O O
Allergies . O O
AZITHROMYCIN NNP B-NP O
- : O O
Unknown JJ O O
Ace NN B-NP O
Inhibitor NNP I-NP O
- : O O
cough NN B-NP O
, , O O
TOB NN B-NP O
: : O O
quit VB B-VP O
2120 CD B-NP B-DATE
; : O O
smoked VBN B-NP O
2ppd JJ I-NP O
x NN I-NP O
15 CD B-NP O
yrs NNS I-NP O
ETOH NNP B-NP O
: : O O
none NN B-NP O
IVDU/illict NNP B-NP O
drugs NNS I-NP O
: : O O
none NN B-NP O
SH NNS B-NP O
: : O O
originally RB B-ADVP O
from IN B-PP O
Mt NNP B-NP B-STATE
. . I-NP O
Married NNP I-NP O
for IN B-PP O
39 CD B-NP O
years NNS I-NP O
to TO B-PP O
Friedman NNP B-NP B-PATIENT
, , O O
describes VBZ B-VP O
marriage NN B-NP O
as IN B-PP O
good JJ B-NP O
, , I-NP O
safe JJ I-NP O
. . O O
Has VBZ B-VP O
2 CD B-NP O
children NNS I-NP O
and CC O O
8 CD B-NP O
grandchildren NNS I-NP O
. . O O
Has VBZ B-VP O
2 CD B-NP O
daugthers NNS I-NP O
, , O O
1 CD B-NP O
lives NNS I-NP O
in IN B-PP O
hartsville NN B-NP B-CITY
and CC I-NP O
1 CD I-NP O
in IN B-PP O
nuku'alofa NN B-NP B-CITY
. . O O
no DT B-NP O
pets NNS I-NP O
. . O O
fulltime NN B-NP O
author NN I-NP B-PROFESSION
. . O O
husband NN B-NP O
has VBZ B-VP O
h/p RB O O
prostate NN B-NP O
CA. NN I-NP O
FH NNP B-NP O
: : O O
( -LRB- O O
no DT B-NP O
known VBN B-VP O
)h/o IN B-PP O
sudden JJ B-NP O
death NN I-NP O
, , O O
hyperlipidemia NN B-NP O
+ NN B-NP O
Dm NN I-NP O
in IN B-PP O
father NN B-NP O
( -LRB- I-NP O
dxd NN I-NP O
in IN B-PP O
his PRP$ B-NP O
60 CD I-NP B-AGE
- : O O
70 CD B-NP B-AGE
) -RRB- O O
+ NN B-NP O
mgm NN I-NP O
w JJ I-NP O
stroke NN I-NP O
( -LRB- O O
+CHF NN B-NP O
in IN B-PP O
ther DT B-NP O
mother NN I-NP O
+m NN B-NP O
Uncles NNS I-NP O
x NN I-NP O
2 CD B-NP O
with IN B-PP O
MIs NNP B-NP O
( -LRB- O O
~ NN B-NP O
60 CD I-NP I-AGE
's POS B-LST I-AGE
( -LRB- B-NP O
no NN I-NP O
known VBN I-NP O
) -RRB- I-NP O
h/o VBD B-VP O
endometrial JJ B-NP O
, , I-NP O
ovarian JJ I-NP O
, , I-NP O
thyroid JJ I-NP O
, , I-NP O
melanoma NN I-NP O
, , I-NP O
breast NN I-NP O
, , O O
prostate NN B-NP O
+ JJ B-NP O
colon NN I-NP O
cancer NN I-NP O
in IN B-PP O
her PRP$ B-NP O
mother NN I-NP O
, , O O
dx RB B-ADVP O
'd MD B-VP O
55 CD B-NP B-AGE
- : O O
60 CD B-NP B-AGE
yo CD I-NP O
( -LRB- O O
no DT B-NP O
known VBN I-NP O
)h/o NN I-NP O
osteoporosis/premature NN I-NP O
bone NN I-NP O
loss NN I-NP O
( -LRB- O O
no DT B-NP O
known VBN B-VP O
)h/o IN B-PP O
colon NN B-NP O
polyp NN I-NP O
, , O O
dysplasic JJ B-NP O
nevi NN I-NP O
( -LRB- O O
no DT B-NP O
known VBN B-VP O
)h/o IN B-PP O
pe NN B-NP O
, , O O
DVT NNP B-NP O
, , O O
miscarriages NNS B-NP O
, , O O
bleeding VBG B-VP O
disorders NNS B-NP O
( -LRB- B-NP O
+ NN I-NP O
)h/o NN I-NP O
glaucoma NN I-NP O
in IN B-PP O
mUncle NN B-NP O
( -LRB- B-NP O
no NN I-NP O
known VBN I-NP O
) -RRB- I-NP O
h/o IN B-PP O
depression NN B-NP O
, , O O
suicide NN B-NP O
, , O O
schizophrenia NN B-NP O
+ NN B-NP O
dementia NN I-NP O
in IN B-PP O
her PRP$ B-NP O
mother NN I-NP O
+alcoholis NNP B-NP O
in IN B-PP O
2 CD B-NP O
muncles NNS I-NP O
+ NN B-NP O
bipolar NN I-NP O
do VBP B-VP O
in IN B-PP O
grandson NN B-NP O
VS NNP B-NP O
: : O O
130/66 CD B-NP O
76 CD I-NP O
97.1 CD I-NP O
98 CD I-NP O
%RA NNP I-NP O
250 CD I-NP O
lbs NNS I-NP O
57.25 CD O O
general JJ B-NP O
: : B-VP O
well RB B-ADJP O
- : O O
appearing VBG B-VP O
F NNP B-NP O
in IN B-PP O
NAD NNP B-NP O
HEENT NNP B-NP O
: : O O
anicteric JJ B-NP O
, , I-NP O
PERRL NNP I-NP O
, , I-NP O
EOMI NNP I-NP O
, , I-NP O
mmm NN I-NP O
; : O O
difficult JJ B-ADVP O
to TO B-VP O
assess VB I-VP O
JVP NNP B-NP O
, , O O
L NNP B-NP O
TM NNP I-NP O
w VBD B-VP O
nearly RB I-VP O
obstructing VBG I-VP O
cerumen NN B-NP O
; : O O
R NN B-NP O
w VBD B-VP O
nl JJ B-NP O
TM NNP I-NP O
and CC O O
light JJ B-NP O
reflex NN I-NP O
. . O O
PULM NNP B-NP O
: : O O
CTAB NNP B-NP O
w VBD B-VP O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
. . O O
no DT B-NP O
wheezes NNPS I-NP O
, , O O
rhonchi NNP B-NP O
, , O O
or CC O O
crackles NNS B-NP O
COR JJ B-NP O
: : O O
rrr NN B-NP O
, , I-NP O
nls1s1 NN I-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP O
EXT NNP B-NP O
: : O O
wwp NN B-NP O
, , O O
no DT B-NP O
edema NN I-NP O
A/P NNP B-NP O
: : O O
61 CD B-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
PMH NNP B-NP O
of IN B-PP O
HTN NNP B-NP O
, , O O
hyperlipidemia NN B-NP O
, , O O
DM NNP B-NP O
, , O O
obesity NN B-NP O
, , O O
bladder NN B-NP O
cancer NN I-NP O
presenting VBG B-VP O
for IN B-PP O
fu NN B-NP O
of IN B-PP O
multiple JJ B-NP O
medical JJ I-NP O
issues NNS I-NP O
. . O O
1 CD B-NP O
) -RRB- I-NP O
DM NNP I-NP O
: : O O
Dx NNP B-NP O
'd MD B-VP O
~ VB I-VP O
2129 CD B-NP B-DATE
, , O O
c/b NN B-NP O
diabetic NN I-NP O
retinopathy NN I-NP O
s/p NN I-NP O
laser NN I-NP O
tx NN I-NP O
and CC O O
likely JJ B-NP O
neuropathy NN I-NP O
. . O O
Most RBS B-NP O
recent JJ I-NP O
10/36 CD I-NP B-DATE
HgbA1c NNP I-NP O
: : O O
7.0 CD B-NP O
% NN I-NP O
, , O O
very RB B-ADVP O
near JJ B-NP O
goal NN I-NP O
of IN B-PP O
&lt JJ B-NP O
;7.0 CD I-NP O
% NN I-NP O
and CC O O
improving VBG B-VP O
compared VBN I-VP O
to TO B-PP O
7.8 CD B-NP O
% NN I-NP O
since IN B-PP O
increase NN B-NP O
in IN B-PP O
lantus NN B-NP O
dose NN I-NP O
. . O O
Did VBD B-VP O
not RB I-VP O
bring VB I-VP O
FS NNS B-NP O
log VBP B-VP O
today NN B-NP O
but CC O O
continues VBZ B-VP O
to TO I-VP O
report VB I-VP O
that IN B-SBAR O
her PRP$ B-NP O
fasting JJ I-NP O
glucose NN I-NP O
in IN B-PP O
AM NNP B-NP O
still RB B-ADVP O
often RB B-ADVP O
above JJ B-NP O
goal NN I-NP O
and CC O O
that IN B-SBAR O
her PRP$ B-NP O
largest JJS I-NP O
meal NN I-NP O
and CC I-NP O
need NN I-NP O
for IN B-PP O
novolg NN B-NP O
is VBZ B-VP O
at IN B-PP O
dinner NN B-NP O
. . O O
Previously RB B-ADVP O
recommended VBD B-VP O
starting VBG I-VP O
BID NNP B-NP O
dosing NN I-NP O
of IN B-PP O
lantus NN B-NP O
and CC O O
adding VBG B-VP O
10 CD B-NP O
units NNS I-NP O
in IN B-PP O
PM NNP B-NP O
, , O O
but CC O O
not RB O O
able JJ B-ADJP O
to TO B-VP O
obtain VB I-VP O
yet RB B-ADVP O
from IN B-PP O
pfizer NN B-NP B-ORGANIZATION
; : O O
discussed VBN B-VP O
that IN B-PRT O
for IN B-PP O
some DT B-NP O
individuals NNS I-NP O
it PRP B-NP O
dose NN B-VP O
not RB B-ADJP O
last JJ I-ADJP O
for IN B-PP O
24 CD B-NP O
hours NNS I-NP O
adn VBP B-VP O
that IN B-SBAR O
they PRP B-NP O
get VBP B-VP O
better JJR B-NP O
glucose NN I-NP O
control NN I-NP O
w WRB B-ADVP O
BID NNP B-NP O
dosing NN I-NP O
. . O O
Discussed VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
will MD B-VP O
likely RB I-VP O
need VB I-VP O
to TO I-VP O
decrease VB I-VP O
her PRP$ B-NP O
PM NNP I-NP O
dose NN I-NP O
of IN B-PP O
novolog NN B-NP O
----recheck JJ B-NP O
hgba1c JJ I-NP O
~ NN I-NP O
1/2137 . O B-DATE
----continue JJ B-NP O
metformin NN I-NP O
1000mg IN B-PP O
BID NNP B-NP O
, , O O
lantus NN B-NP O
65units VBZ B-VP O
qam NN B-NP O
and CC I-NP O
novolog NN I-NP O
70/30 . O O
but CC O O
also RB B-VP O
adding VBG I-VP O
10 CD B-NP O
units NNS I-NP O
of IN B-PP O
lantus NN B-NP O
in IN B-PP O
PM NNP B-NP O
----continue JJ B-NP O
glucose NN I-NP O
monitoring NN I-NP O
for IN B-PP O
likely JJ B-NP O
need NN I-NP O
for IN B-PP O
further JJ B-NP O
adjustments NNS I-NP O
to TO B-VP O
regimen VB I-VP O
---- : O O
7/36 CD B-NP B-DATE
urine NN I-NP O
microalbumin/crt NN I-NP O
: : O O
35.9 CD B-NP O
above JJ I-NP O
goal NN I-NP O
of IN B-PP O
&lt;30 CD B-NP O
; : O O
have VB B-NP O
made VBN I-NP O
changes NNS I-NP O
to TO B-PP O
BP NNP B-NP O
regimen NNS I-NP O
and CC O O
BP NNP B-NP O
now RB B-ADVP O
within IN B-PP O
goal NN B-NP O
; : O O
will MD B-VP O
recheck VB I-VP O
u PRP B-NP O
microalb/crt NN B-NP O
in IN B-PP O
1/2137 CD B-NP B-DATE
----OPTHO NN B-NP O
: : O O
followd NN B-NP O
by IN B-PP O
dr NN B-NP O
arias NNS I-NP B-DOCTOR
; : O O
reports NNS B-NP O
uptodate NN I-NP O
----PODIOTRY NN B-NP O
: : O O
pt NN B-NP O
w WRB B-ADVP O
likely JJ B-NP O
diabetic NN I-NP O
neuropathy NN I-NP O
and CC I-NP O
e/o NN I-NP O
oncychomycosis NN I-NP O
; : O O
referrred VBN B-VP O
to TO I-VP O
podiotry VB I-VP O
for IN B-PP O
further JJ B-NP O
care NN I-NP O
and CC I-NP O
monitoring NN I-NP O
at IN B-PP O
previous JJ B-NP O
visit NN I-NP O
----BP JJ B-NP O
: : O O
within IN B-PP O
goal NN B-NP O
on IN B-PP O
HCTZ NNP B-NP O
, , O O
Cozzar NNP B-NP O
, , O O
metoprolol NN B-NP O
and CC O O
norvasc NN B-NP O
---- : O O
2136 CD B-NP B-DATE
LDL NNP I-NP O
: : O O
114 CD B-NP O
above JJ I-NP O
goal NN I-NP O
of IN B-PP O
&lt JJ B-NP O
;100 CD I-NP O
, , O O
not RB B-ADVP O
on IN B-PP O
statin NN B-NP O
; : O O
started VBN B-NP O
simvastatin IN B-PP O
which WDT B-NP O
was VBD B-VP O
dc JJ B-NP O
'd MD B-VP O
2/2 VB I-VP O
myalgias NNS B-NP O
and CC O O
generalized JJ B-NP O
weakness NN I-NP O
( -LRB- I-NP O
nl NN I-NP O
LFTS NNS I-NP O
and CC O O
CK) NNP B-NP O
; : O O
pt NN B-NP O
has VBZ B-VP O
started VBN I-VP O
pravastain RB B-ADVP O
and CC O O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
doing VBG I-VP O
well RB B-ADVP O
on IN B-PP O
this DT B-NP O
---- : O O
9/36 CD B-NP B-DATE
Gabriella NNP I-NP B-DOCTOR
Yockey NNP I-NP I-DOCTOR
----discussed JJ B-NP O
nutrition NN I-NP O
referral NN I-NP O
; : O O
pt NN B-NP O
declined VBD B-VP O
but CC O O
plans NNS B-NP O
on IN B-PP O
joining VBG B-VP O
south JJ B-NP B-ORGANIZATION
beach NN I-NP I-ORGANIZATION
diet NN I-NP I-ORGANIZATION
----discussed JJ B-NP O
importance NN I-NP O
of IN B-PP O
wt JJ B-NP O
loss NN I-NP O
; : O O
pt NN B-NP O
to TO B-VP O
try VB I-VP O
south JJ B-NP B-ORGANIZATION
beach NN I-NP I-ORGANIZATION
diet NN I-NP I-ORGANIZATION
; : O O
----PNEUMOVAX NNP B-NP O
: : O O
2136 CD O B-DATE
----Flu NNP B-NP O
shot/H1N1 NN I-NP O
: : O O
flu NN B-NP O
shot NN I-NP O
uptodate NN I-NP O
; : O O
receiving VBG B-VP O
h1n1 NN B-NP O
today NN I-NP O
2 CD B-NP O
) -RRB- I-NP O
HTN NN I-NP O
: : O O
Dx NNP B-NP O
'd NNP I-NP O
in IN B-PP O
~ NNP B-NP O
2129 CD I-NP B-DATE
. . O O
BP NNP B-NP O
very RB I-NP O
near JJ I-NP O
goal NN I-NP O
today NN I-NP O
on IN B-PP O
current JJ B-NP O
regimen NNS I-NP O
of IN B-PP O
HCTZ NNP B-NP O
25mg CD I-NP O
qd NN I-NP O
, , O O
cozaar NN B-NP O
50mg CD I-NP O
BId NNP I-NP O
, , O O
metoprolol NN B-NP O
100mg CD I-NP O
BID NNP I-NP O
and CC I-NP O
norvasc JJ I-NP O
5 CD I-NP O
mg NN I-NP O
qd NN I-NP O
which WDT B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
well-tolerated JJ B-ADJP O
. . O O
Will MD B-VP O
not RB I-VP O
make VB I-VP O
any DT B-NP O
additional JJ I-NP O
changes NNS I-NP O
since IN B-PP O
pt NN B-NP O
is VBZ B-VP O
planning VBG I-VP O
on IN B-PP O
adding VBG B-VP O
imdur NN B-NP O
30mg NN I-NP O
as RB B-ADVP O
soon RB I-ADVP O
as IN B-SBAR O
she PRP B-NP O
received VBD B-VP O
it PRP B-NP O
from IN B-PP O
Pfizer NNP B-NP B-ORGANIZATION
. . O O
10/2136 CD B-NP B-DATE
chem NN I-NP O
7 CD B-NP O
, , O O
renal JJ B-NP O
fxn NN I-NP O
, , O O
ca MD B-VP O
wnl RB I-VP O
. . O O
-----encouraged JJ B-NP O
low JJ I-NP O
na TO B-PP O
diet NN B-NP O
, , O O
wt NN B-NP O
loss NN I-NP O
----continue JJ B-NP O
HCTZ NNP I-NP O
25mg CD I-NP O
qd NN I-NP O
, , O O
cozaar NN B-NP O
50mg CD I-NP O
BId NNP I-NP O
, , O O
and CC O O
metoprolol JJ B-NP O
100mg JJ I-NP O
BID NNP I-NP O
, , O O
and CC O O
norvasc JJ B-NP O
5 CD I-NP O
mg NN I-NP O
qd NN I-NP O
----reviewed JJ B-NP O
si/sxs NNS I-NP O
for IN B-PP O
which WDT B-NP O
she PRP B-NP O
should MD B-VP O
seek VB I-VP O
immediate JJ B-NP O
medical JJ I-NP O
attention NN I-NP O
3 CD B-NP O
) -RRB- I-NP O
dyslipidemia NN I-NP O
: : O O
7/36 CD B-NP B-DATE
LDL NNP I-NP O
114 CD I-NP O
above IN B-PP O
goal NN B-NP O
of IN B-PP O
&lt JJ B-NP O
;100 CD I-NP O
given VBN I-NP O
DM NNP I-NP O
and CC O O
likely JJ B-NP O
CAD. NNP I-NP O
Pt NNP I-NP O
w VBD B-VP O
brief JJ B-NP O
2 CD I-NP O
week NN I-NP O
trial NN I-NP O
of IN B-PP O
simvastatin NN B-NP O
self-dc JJ I-NP O
'd MD B-VP O
2/2 VB I-VP O
myalgias NNS B-NP O
and CC O O
generalized JJ B-NP O
weakness NN I-NP O
but CC O O
nl NN B-NP O
LFTS/CK/GFR. NNP I-NP O
Pt NNP I-NP O
now RB B-ADVP O
on IN B-PP O
pravastatin NN B-NP O
x NN I-NP O
2 CD B-NP O
weeks NNS I-NP O
and CC O O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
well-tolerated JJ B-ADJP O
thus RB B-ADVP O
far RB I-ADVP O
. . B-VP O
Again RB I-VP O
reviewed VBN I-VP O
possible JJ B-NP O
side NN I-NP O
effects NNS I-NP O
and CC O O
she PRP B-NP O
knows VBZ B-VP O
to TO I-VP O
call VB I-VP O
w RB B-ADVP O
any DT B-NP O
concerns NNS I-NP O
or CC I-NP O
questions NNS I-NP O
----continue JJ B-NP O
pravastatin NN I-NP O
20mg IN B-PP O
qhs NNS B-NP O
; : O O
reivwed VBN B-NP O
possible JJ I-NP O
side NN I-NP O
effects NNS I-NP O
and CC O O
instructed VBN B-VP O
to TO I-VP O
call VB I-VP O
w JJ B-NP O
concerns NNS I-NP O
----pt JJ B-NP O
instructed VBD B-VP O
that IN B-SBAR O
she PRP B-NP O
will MD B-VP O
need VB I-VP O
repeat NN B-NP O
lipids NNS I-NP O
and CC O O
LFTS NNS B-NP O
in IN B-PP O
~ JJ B-NP O
6-8 CD I-NP O
weeks NNS I-NP O
after IN B-PP O
starting VBG B-VP O
pravasatin NN B-NP O
; : O O
will MD B-VP O
check VB I-VP O
at IN B-PP O
next JJ B-NP O
visit NN I-NP O
----recommended JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
diet NN I-NP O
4 CD B-NP O
) -RRB- I-NP O
Likely RB I-NP O
stable JJ I-NP O
angina/CAD NN I-NP O
; : O O
now RB B-ADJP O
s/p JJ I-ADJP O
Cardiology NNP B-NP O
, , O O
consult VB B-VP O
w JJ B-NP O
Dr. NNP I-NP O
Uphoff NNP I-NP B-DOCTOR
who WP B-NP O
feels VBZ B-VP O
that IN B-PP O
clinical JJ B-NP O
presentation NN I-NP O
c/w NN I-NP O
stable JJ I-NP O
angina/CAD NN I-NP O
and CC O O
has VBZ B-VP O
recommended VBN B-NP O
trial NN I-NP O
of IN B-PP O
optimizing JJ B-NP O
medical JJ I-NP O
management NN I-NP O
w NN I-NP O
nitrates NNS I-NP O
and CC O O
BB/CCB NNP B-NP O
for IN B-PP O
now RB B-NP O
. . O O
Reviewed VBN B-VP O
consult VB I-VP O
recs JJ B-ADJP O
with IN B-PP O
patient NN B-NP O
. . O O
however RB B-ADVP O
, , O O
if IN B-SBAR O
this DT B-NP O
does VBZ B-VP O
not RB I-VP O
work VB I-VP O
, , O O
will MD B-VP O
consider VB I-VP O
possible JJ B-NP O
cath/stress NN I-NP O
test NN I-NP O
. . O O
pt NN B-NP O
appears VBZ B-VP O
to TO I-VP O
be VB I-VP O
tolerating JJ B-NP O
increase NN I-NP O
in IN B-PP O
BB NNP B-NP O
and CC O O
has VBZ B-VP O
not RB I-VP O
yet RB I-VP O
started VBN I-VP O
imdur RB B-ADVP O
. . O O
recent JJ O O
LDL NNP B-NP O
above IN B-PP O
goal NN B-NP O
but CC O O
just RB B-NP O
restarted VBN I-NP O
statin NN I-NP O
so RB B-ADVP O
will MD B-VP O
need VB I-VP O
fu NN B-NP O
measurement NN I-NP O
in IN B-PP O
~ JJ B-NP O
4 CD I-NP O
weeks NNS I-NP O
. . O O
----continue JJ B-NP O
asa NN I-NP O
81 CD I-NP O
mg NN I-NP O
qd NN I-NP O
; : O O
increased VBN B-NP O
metoprolol NN I-NP O
100mg IN B-PP O
BID NNP B-NP O
, , O O
ARB NNP B-NP O
, , O O
and CC O O
pravastatin VBG B-VP O
20mg JJ B-NP O
qhs NNS I-NP O
----fu NN B-NP O
appt NN I-NP O
w VBD B-VP O
dr JJ B-NP O
uphoff NN I-NP B-DOCTOR
in IN B-PP O
~ NN B-NP O
1 CD B-NP O
week NN I-NP O
----pt JJ B-ADJP O
to TO B-VP O
add VB I-VP O
imdur RB B-NP O
30mg JJ I-NP O
as RB B-ADVP O
soon RB I-ADVP O
as IN B-SBAR O
arrives VBZ B-VP O
from IN B-PP O
pharmacy NN B-NP O
5 CD B-NP O
) -RRB- I-NP O
Left VBN I-NP O
ear NN I-NP O
impaction NN I-NP O
: : O O
Left VBN B-VP O
TM NNP B-NP O
w VBD B-VP O
nearly RB B-ADVP O
completely RB I-ADVP O
obstructing JJ B-NP O
cerumen NNS I-NP O
. . O O
Irrigated NNP B-NP O
ear NN I-NP O
w VBD B-VP O
full JJ B-NP O
removal NN I-NP O
and CC I-NP O
visualizatino NN I-NP O
of IN B-PP O
nl DT B-NP O
TM NNP I-NP O
post NN I-NP O
irrigation NN I-NP O
. . O O
Pt '' O O
confirms VBZ B-VP O
complete JJ B-NP O
resolution NN I-NP O
of IN B-PP O
sxs NNS B-NP O
w VBD B-VP O
return NN B-NP O
of IN B-PP O
nl JJ B-NP O
hearing NN I-NP O
. . O O
pt NN O O
felt VBD B-VP O
well RB I-VP O
post VB I-VP O
irrigation NN B-NP O
w WRB B-ADVP O
no DT B-NP O
dizziness NN I-NP O
. . B-NP O
disucsed VBD B-VP O
possible JJ B-NP O
dizziness NN I-NP O
and CC O O
she PRP B-NP O
will MD B-VP O
sit VB I-VP O
in IN B-PP O
waiting NN B-NP O
room NN I-NP O
for IN B-PP O
a DT B-NP O
while NN I-NP O
and CC O O
make VB B-VP O
sure JJ B-ADJP O
that IN B-SBAR O
she PRP B-NP O
does VBZ B-VP O
not RB I-VP O
experience VB I-VP O
. . O O
6 CD B-NP O
) -RRB- I-NP O
HCM NNP I-NP O
: : O O
----recevied JJ B-NP O
flu NN I-NP O
shot NN I-NP O
----will NN B-NP O
give VBP B-VP O
h1n1 PRP B-NP O
today NN B-NP O
---will NN B-NP O
give VBP B-VP O
tdap NN B-NP O
today NN I-NP O
To TO B-VP O
DO VB I-VP O
; : O O
----fu NN B-NP O
on IN B-PP O
mammogram NN B-NP O
---continue JJ B-ADJP O
to TO B-VP O
discuss VB I-VP O
colonscopy NN B-NP O
Pt NNP B-ADJP O
to TO B-VP O
RTc NNP B-NP O
in IN B-PP O
~ NNP B-NP O
1 CD I-NP O
mos NNPS I-NP O
or CC I-NP O
sooner RBR I-NP O
if IN B-SBAR O
needed VBN B-VP O
. . O O
